Stay updated with breaking news from Processa Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Free Report) are set to reverse split before the market opens on Monday, January 22nd. The 1-20 reverse split was announced on Monday, January 22nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, January 22nd. Processa Pharmaceuticals Stock Performance NASDAQ […]
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market opening Friday, the Dow traded up 0.18% to 37,536.76 while the NASDAQ rose 0.38% to 15,113.04. The S&P 500 also rose, gaining, 0.19% to 4,790.00.
By Chris Wack Processa Pharmaceuticals shares were up 60% to 32 cents in premarket trading after the company said it plans to expand the development of Next...
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 0.95% to 37,824.10 while the NASDAQ rose 1.39% to 15,264.30. The S&P 500 also rose, gaining, 1.06% to 4,831.75.